Artículos de revistas sobre el tema "Drug-tolerant Mtb"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 28 mejores artículos de revistas para su investigación sobre el tema "Drug-tolerant Mtb".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Mishra, Richa, Sakshi Kohli, Nitish Malhotra, Parijat Bandyopadhyay, Mansi Mehta, MohamedHusen Munshi, Vasista Adiga et al. "Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis". Science Translational Medicine 11, n.º 518 (13 de noviembre de 2019): eaaw6635. http://dx.doi.org/10.1126/scitranslmed.aaw6635.
Texto completoVilchèze, Catherine, Travis Hartman, Brian Weinrick, Paras Jain, Torin R. Weisbrod, Lawrence W. Leung, Joel S. Freundlich y William R. Jacobs. "Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis". Proceedings of the National Academy of Sciences 114, n.º 17 (10 de abril de 2017): 4495–500. http://dx.doi.org/10.1073/pnas.1704376114.
Texto completoLim, Juhyeon, Jae Jin Lee, Sun-Kyung Lee, Seoyong Kim, Seok-Yong Eum y Hyungjin Eoh. "Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia". Proceedings of the National Academy of Sciences 118, n.º 35 (23 de agosto de 2021): e2105800118. http://dx.doi.org/10.1073/pnas.2105800118.
Texto completoLiu, Yancheng, Shumin Tan, Lu Huang, Robert B. Abramovitch, Kyle H. Rohde, Matthew D. Zimmerman, Chao Chen, Véronique Dartois, Brian C. VanderVen y David G. Russell. "Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo". Journal of Experimental Medicine 213, n.º 5 (25 de abril de 2016): 809–25. http://dx.doi.org/10.1084/jem.20151248.
Texto completoFattorini, Lanfranco, Giovanni Piccaro, Alessandro Mustazzolu y Federico Giannoni. "TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS". Mediterranean Journal of Hematology and Infectious Diseases 5, n.º 1 (19 de noviembre de 2013): e2013072. http://dx.doi.org/10.4084/mjhid.2013.072.
Texto completoSaito, Kohta, Thulasi Warrier, Selin Somersan-Karakaya, Lina Kaminski, Jianjie Mi, Xiuju Jiang, Suna Park et al. "Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations". Proceedings of the National Academy of Sciences 114, n.º 24 (30 de mayo de 2017): E4832—E4840. http://dx.doi.org/10.1073/pnas.1705385114.
Texto completoGenestet, Charlotte, Elisabeth Hodille, Alexia Barbry, Jean-Luc Berland, Jonathan Hoffmann, Emilie Westeel, Fabiola Bastian et al. "Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion". PLOS Pathogens 17, n.º 6 (24 de junio de 2021): e1009643. http://dx.doi.org/10.1371/journal.ppat.1009643.
Texto completoIacobino, Angelo, Lanfranco Fattorini y Federico Giannoni. "Drug-Resistant Tuberculosis 2020: Where We Stand". Applied Sciences 10, n.º 6 (22 de marzo de 2020): 2153. http://dx.doi.org/10.3390/app10062153.
Texto completoYadav, Pramod. "Challenges & Solutions for Recent Advancements in Multi-Drugs Resistance Tuberculosis: A Review". Microbiology Insights 16 (enero de 2023): 117863612311524. http://dx.doi.org/10.1177/11786361231152438.
Texto completoChoudhury, Sreetama, Ajay Suresh Akhade y Naeha Subramanian. "Dual RNA-seq as an effective tool to simultaneously identify transcriptional changes in host macrophages and invading intracellular pathogens". Journal of Immunology 204, n.º 1_Supplement (1 de mayo de 2020): 227.27. http://dx.doi.org/10.4049/jimmunol.204.supp.227.27.
Texto completoIvanenko, N. "BIOFILM AND TUMOR: INTERPRETATION OF INTERACTION AND TREATMENT STRATEGIES. Review". Medical Science of Ukraine (MSU) 17, n.º 1 (30 de marzo de 2021): 104–20. http://dx.doi.org/10.32345/2664-4738.1.2021.13.
Texto completoLin, Haifeng, Jie Ma, Manyun Zhuo, Chengsheng Zhang, Jingru Luo, Xiaohong Zhuang, Zhiming Zeng y Lihua Yang. "Preliminary results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma." Journal of Clinical Oncology 39, n.º 3_suppl (20 de enero de 2021): 314. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.314.
Texto completoSamuels, Amanda N., Erin R. Wang, Gregory A. Harrison, Joy C. Valenta y Christina L. Stallings. "Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance". Frontiers in Cellular and Infection Microbiology 12 (22 de agosto de 2022). http://dx.doi.org/10.3389/fcimb.2022.958555.
Texto completoKreutzfeldt, Kaj M., Robert S. Jansen, Travis E. Hartman, Alexandre Gouzy, Ruojun Wang, Inna V. Krieger, Matthew D. Zimmerman et al. "CinA mediates multidrug tolerance in Mycobacterium tuberculosis". Nature Communications 13, n.º 1 (22 de abril de 2022). http://dx.doi.org/10.1038/s41467-022-29832-1.
Texto completoEoh, Hyungjin, Rachel Liu, Juhyeon Lim, Jae Jin Lee y Philip Sell. "Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis". Frontiers in Cellular and Infection Microbiology 12 (22 de agosto de 2022). http://dx.doi.org/10.3389/fcimb.2022.958240.
Texto completoSarathy, Jansy P., Min Xie, Richard M. Jones, Adrienne Chang, Paulina Osiecki, Danielle Weiner, Wen-Shan Tsao et al. "A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum". mBio, 5 de abril de 2023. http://dx.doi.org/10.1128/mbio.00598-23.
Texto completoShankaran, Deepthi, Anjali Singh, Stanzin Dawa, Prabhakar Arumugam, Sheetal Gandotra y Vivek Rao. "The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy". eLife 12 (11 de enero de 2023). http://dx.doi.org/10.7554/elife.64834.
Texto completoKhan, Mehak Zahoor y Vinay Kumar Nandicoori. "Deletion of pknG Abates Reactivation of Latent Mycobacterium tuberculosis in Mice". Antimicrobial Agents and Chemotherapy 65, n.º 4 (18 de marzo de 2021). http://dx.doi.org/10.1128/aac.02095-20.
Texto completoImmanuel, Selva Rupa Christinal, Mario L. Arrieta-Ortiz, Rene A. Ruiz, Min Pan, Adrian Lopez Garcia de Lomana, Eliza J. R. Peterson y Nitin S. Baliga. "Quantitative prediction of conditional vulnerabilities in regulatory and metabolic networks using PRIME". npj Systems Biology and Applications 7, n.º 1 (diciembre de 2021). http://dx.doi.org/10.1038/s41540-021-00205-6.
Texto completoTükenmez, Hasan, Souvik Sarkar, Saber Anoosheh, Anastasiia Kruchanova, Isabel Edström, Gregory A. Harrison, Christina L. Stallings, Fredrik Almqvist y Christer Larsson. "Mycobacterium tuberculosis Rv3160c is a TetR-like transcriptional repressor that regulates expression of the putative oxygenase Rv3161c". Scientific Reports 11, n.º 1 (15 de enero de 2021). http://dx.doi.org/10.1038/s41598-021-81104-y.
Texto completoDe Siena, Barbara, Nicoletta Campolattano, Gianluca D’Abrosca, Luigi Russo, Daire Cantillon, Rosangela Marasco, Lidia Muscariello, Simon J. Waddell y Margherita Sacco. "Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux". Frontiers in Microbiology 11 (3 de diciembre de 2020). http://dx.doi.org/10.3389/fmicb.2020.575828.
Texto completoSrinivas, Vivek, Mario L. Arrieta-Ortiz, Amardeep Kaur, Eliza J. R. Peterson y Nitin S. Baliga. "PerSort Facilitates Characterization and Elimination of Persister Subpopulation in Mycobacteria". mSystems 5, n.º 6 (1 de diciembre de 2020). http://dx.doi.org/10.1128/msystems.01127-20.
Texto completoMitini-Nkhoma, Steven C., Elizabeth T. Chimbayo, David T. Mzinza, David V. Mhango, Aaron P. Chirambo, Christine Mandalasi, Agness E. Lakudzala, Dumizulu L. Tembo, Kondwani C. Jambo y Henry C. Mwandumba. "Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents". Frontiers in Immunology 12 (24 de junio de 2021). http://dx.doi.org/10.3389/fimmu.2021.665785.
Texto completoMavi, Parminder Singh, Shweta Singh y Ashwani Kumar. "Media component bovine serum albumin facilitates the formation of mycobacterial biofilms in response to reductive stress". BMC Microbiology 23, n.º 1 (20 de abril de 2023). http://dx.doi.org/10.1186/s12866-023-02853-6.
Texto completoYamamoto, Kentaro, Noboru Nakata, Tetsu Mukai, Ikuro Kawagishi y Manabu Ato. "Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis". mSphere 6, n.º 1 (6 de enero de 2021). http://dx.doi.org/10.1128/msphere.00518-20.
Texto completoHasenoehrl, Erik J., Thomas J. Wiggins y Michael Berney. "Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis". Frontiers in Cellular and Infection Microbiology 10 (11 de enero de 2021). http://dx.doi.org/10.3389/fcimb.2020.611683.
Texto completoGoyal, Akanksha, Maria Hauswald, Helen McCallum, Gerald Hoebarth y Annette Feussner. "Fit-for-purpose validation of a drug-tolerant immunogenicity assay for a human mAb drug in animal safety studies". Journal of Immunological Methods, diciembre de 2022, 113406. http://dx.doi.org/10.1016/j.jim.2022.113406.
Texto completoKilany, Lobna Abdel Aziz, Ayman Abdel Samie Gaber, Mohammad Mabrouk Aboulwafa y Hamdallah Hafez Zedan. "Trastuzumab immunogenicity development in patients’ sera and in laboratory animals". BMC Immunology 22, n.º 1 (19 de febrero de 2021). http://dx.doi.org/10.1186/s12865-021-00405-z.
Texto completo